Kamada LtdNASDAQ:KMDA
- LAST PRICE5.8500
- TODAY'S CHANGE (%)0.0300 (0.5155%)
- Bid / Lots4.5100/ 1
- Ask / Lots6.0400/ 1
- Open / Previous Close5.8600 / 5.8200
- Day Range
- 52 Week Range
- Volume23,357
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KMDA |
|---|---|---|
| 09:32 ET | 1795 | 5.86 |
| 09:33 ET | 1900 | 5.8602 |
| 10:02 ET | 2100 | 5.8502 |
| 10:26 ET | 443 | 5.85 |
| 10:27 ET | 109 | 5.845 |
| 10:38 ET | 999 | 5.83 |
| 11:20 ET | 432 | 5.8 |
| 11:25 ET | 100 | 5.83 |
| 11:32 ET | 812 | 5.85 |
| 11:54 ET | 300 | 5.814 |
| 11:59 ET | 1441 | 5.86 |
| 12:08 ET | 100 | 5.84 |
| 12:15 ET | 160 | 5.8121 |
| 12:35 ET | 100 | 5.82 |
| 12:46 ET | 121 | 5.81 |
| 01:00 ET | 100 | 5.8128 |
| 01:02 ET | 100 | 5.82 |
| 01:40 ET | 100 | 5.84 |
| 02:12 ET | 200 | 5.83 |
| 02:16 ET | 100 | 5.81 |
| 02:23 ET | 100 | 5.8108 |
| 03:17 ET | 200 | 5.82 |
| 03:19 ET | 1215 | 5.82 |
| 03:21 ET | 100 | 5.825 |
| 03:24 ET | 100 | 5.8299 |
| 03:26 ET | 100 | 5.825 |
| 03:32 ET | 2243 | 5.82 |
| 03:33 ET | 1236 | 5.82 |
| 03:35 ET | 900 | 5.84 |
| 03:42 ET | 100 | 5.835 |
| 03:46 ET | 100 | 5.835 |
| 03:50 ET | 200 | 5.835 |
| 03:51 ET | 200 | 5.835 |
| 03:55 ET | 100 | 5.835 |
| 03:57 ET | 200 | 5.835 |
| 04:00 ET | 861 | 5.85 |
Nov 14, 2024
DJ Kamada Price Target Maintained With a $11.00/Share by HC Wainwright & Co., from 1:56PM ET on Thursday Nov 14, 2024 by Dow Jones
1:56PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow JonesPress Release: Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 6, 2024
Kamada to Announce Third Quarter and Nine-Months Ended September 30, 2024 Financial Results and Host Conference Call on November 13, 2024, from 7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 4, 2024
Kamada to Present at the Stifel 2024 Healthcare Conference, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kamada Ltd | 336.3M | 18.9x | -22.48% |
Sutro Biopharma Inc | 207.4M | -1.6x | --- |
Karyopharm Therapeutics Inc | 97.4M | -1.0x | --- |
Sangamo Therapeutics Inc | 408.1M | -2.8x | --- |
Heron Therapeutics Inc | 160.8M | -5.8x | --- |
Arcturus Therapeutics Holdings Inc | 462.4M | -7.3x | --- |
Company Information
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Contact Information
- Headquarters
- 2 Holtzman St., Science ParkREHOVOT, Israel 7670402
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Lilach Asher Topilsky
- Chief Executive Officer
- Amir London
- Deputy Chairman of the Board
- David Tsur
- Chief Financial Officer
- Chaime Orlev
- Senior Vice President - Scientific Affairs
- Ruth Wolfson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $336.3M |
|---|---|
Revenue (TTM) | $158.4M |
Shares Outstanding | 57.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $0.31 |
Book Value | $4.25 |
P/E Ratio | 18.9x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | 11.7x |
Operating Margin | 11.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
